Karyopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY Trial in Myelofibrosis Transcript
Corroborated by 1 source from 1 publisher
globalcrime3h ago
TL;DR
According to seekingalpha.com, company Participants Brendan Strong - Senior Vice President of Investor Relations Richard Paulson - President, CEO & Director Reshma Rangwala - Executive VP, Chief Medical Officer & Head of Research Conference Call Participants John Mascarenhas Edward Tenthoff - Piper Sandler & Co., Research Division Colleen Hanley - Robert W.